In parallel, a British consortium performed targeted sequencing of 293-genes and defined five molecular subtypes [27], demonstrating partial overlap with the initial two WES studies [24,25], which includes NOTCH2-C1-BN2, BCL2-C3-EZB, and MYD88-C5-MCD, and leaving 27% of the DLBCL cases unclassified. Here, BCL2 is linked to diffuse large B-cell lymphoma.